Aurora Cannabis urges holders to reject Curaleaf's revised hostile bid

Aurora Cannabis's board unanimously reaffirmed that shareholders should reject Curaleaf's revised hostile offer, filed October 6. The board says the bid still significantly undervalues the debt-free company. A special committee is evaluating strategic alternatives, and Curaleaf's offer stays open until December 4, 2026.

Why it matters: The fight sets up a potential bidding contest or white-knight outcome in the consolidating cannabis sector.